A Phase I Dose-Escalation Study of Intravenous Panobinostat in Patients With Lymphoma and Solid Tumors

Investigational New Drugs - Netherlands
doi 10.1007/s10637-013-9930-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC